Reveal Biosciences Company

Reveal brings AI into pathology to diagnose disease from large whole slide microscope images. This is a new class of diagnostics offering fundamental improvements to reach, cost, speed, accuracy and scale in how disease is diagnosed. Reveal's computational pathology technology combines a histopathology laboratory with machine learning models applied to tissue biology problems. The computer aided characterization and diagnosis products locate and measure cells, tissue and tissue architecture needed to generate diagnostic assessment that can truly impact healthcare.
Technology: P4 Medicine
Industry: Artificial Intelligence, Biotechnology, Health Diagnostics, Machine Learning
Headquarters: San Diego, California, United States
Founded Date: 2012-08-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 3
Estimated Revenue: $1M to $10M
Last Funding Type: Series A

Visit Website
claris@revealbio.com
https://twitter.com/revealbio
Register and Claim Ownership